Table 3 The summation of success rate according to the mean PAS after treatment at 3, 6, 12 month follow-up in both study groups
Group I (N = 85) | Group II (N = 86 ) | P value | |||||
|---|---|---|---|---|---|---|---|
3MS | 6MS | 12MS | 3MS | 6MS | 12MS | ||
aNo pain, N (%) | 20 (23.52%) | 18 (21.17%) | 18 (21.17%) | 21 (24.41%) | 19 (22.09%) | 18 (20.93%) | NS |
bMinimal pain, N (%) | 19 (22.35%) | 19 (22.35%) | 17 (20%) | 20 (23.25%) | 19 (22.09%) | 18 (20.93%) | NS |
cTolerable pain, N (%) | 27 (31.76%) | 28 (32.94%) | 28 (32.94%) | 27 (31.39%) | 28 (32.55%) | 27 (31.39%) | NS |
dSevere pain, N (%) | 19 (22.35%) | 20 (23.52%) | 22 (25.88%) | 18 (20.93%) | 21 (24.41%) | 22 (25.58%) | NS |
Overall success rate | (66/85) (77.64%) | (65/85) (76.47%) | (63/85) 74.11% | (68/86) 79.06% | (65/86) 75.58 % | (63/86) 73.25% | NS |